Company intelligence / Profile preview

Sauvie Inc.

Short Hills, New Jersey, United Statessauvieisland.org ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

Sauvie Inc. is developing transformational immuno-oncology therapies using its proprietary CAM-V™ single-domain antibody platform and a nanobody-based bispecific NK cell engager targeting HER2+ cancers. The company has entered into an exclusive worldwide license agreement with Rutgers University for this technology. Early-stage research has demonstrated high affinity and specificity for the anti-HER2 VHH, as well as promising preclinical data for their BiKE (bispecific killer engager) approach.[1][3] No human clinical results have been reported publicly.

Therapeutic areas: Oncology
Modalities: Single-domain antibodiesBispecific NK cell engagers
Industry: Biotech

Drug pipeline

2 assets

Program 3 (Sauvie Inc.)

Preclinical

1 more asset in the full pipeline.

Request access →

Partnerships

Rutgers University – exclusive worldwide license agreement for bi-specific NK cell engager technology in oncology

Beyond the preview

Go deeper on Sauvie Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sauvie Inc..

Explore the full profile